PCOS (Polycystic Ovary Syndrome)

Definition

PCOS is one of the most common endocrine disorders in women, affecting an estimated 8 to 13% of reproductive-age women worldwide. It is diagnosed using the Rotterdam criteria, requiring two of three features: irregular or absent ovulation (oligo- or anovulation), clinical or biochemical signs of elevated androgens (testosterone, DHEA-S), and polycystic ovarian morphology on ultrasound. PCOS has four recognized phenotypes with varying presentations. Critically, PCOS is not only a reproductive disorder — it is a metabolic condition. The majority of women with PCOS have insulin resistance, regardless of body weight. They have elevated cardiovascular risk, higher rates of type 2 diabetes, non-alcoholic fatty liver disease, sleep apnea, anxiety, and depression. Its metabolic roots make it highly relevant to SPOKEmed’s integrated metabolic-hormonal approach.

Frequently Asked Question

Is PCOS just a reproductive problem or does it affect overall health?

PCOS is primarily a metabolic-hormonal disorder that also affects reproduction. The metabolic consequences — insulin resistance, elevated cardiovascular risk, elevated diabetes risk, inflammatory dysregulation, and sleep apnea — are at least as clinically significant as the reproductive symptoms. Managing PCOS only by regulating cycles misses the majority of its long-term health implications.

Does PCOS get better or worse at menopause?

Menstrual irregularity from PCOS typically resolves at menopause since cycles cease. However, the underlying metabolic dysfunction — insulin resistance, androgen dysregulation, and cardiovascular risk — persists and may worsen without targeted management. Women with PCOS entering perimenopause often face compounded metabolic challenges and require more attentive clinical oversight than women without PCOS.

Is birth control the only treatment for PCOS?

No — and for many women, it is not the best first-line approach. Birth control pills address cycle irregularity but do not treat the underlying insulin resistance or metabolic dysfunction driving PCOS. Evidence-based interventions targeting insulin sensitivity — including targeted nutrition, physical activity, GLP-1 medications, and metformin — can address both the hormonal and metabolic dimensions simultaneously and produce more durable results.

Why PCOS (Polycystic Ovary Syndrome) Matters

PCOS is frequently managed with birth control pills to regulate cycles — which addresses the symptom without the metabolic root cause. Women with PCOS who arrive in perimenopause often have years of unaddressed insulin resistance compounding their hormonal transition. Comprehensive metabolic and hormonal evaluation is essential.

How Spokmed Company Uses It

SPOKEmed evaluates PCOS within the context of both its hormonal and metabolic dimensions. Testing includes hormone levels (LH, FSH, androgens), metabolic markers (fasting insulin, glucose, A1C), and when indicated the DUTCH test for a fuller hormone metabolite picture. Treatment addresses insulin resistance, metabolic dysfunction, and hormonal imbalance as an integrated strategy — not birth control as the default.

Related Services

Related Terms

"PCOS (Polycystic Ovary Syndrome)" Appears in These Categories

Hormone Health & Life Stage Transitions